MedTrace Logo

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

NCT00270881 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2012-04-06

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the safety and efficacy of cord blood transplantation for adult patients with hematologic malignancies including refractory acute leukemia. The transplant procedure was determined in detail according to the previously published report showing a high survival, so that the investigators could expect a similar result.

Conditions

Interventions

PROCEDURE

Cord blood transplantation

unrelated cord blood transplantation

RADIATION

TBI

Total body irradiation (TBI) 12Gy

DRUG

cyclophosphamide

cyclophosphamide 120mg/kg

DRUG

cytarabine

cytarabine 3g/m2x4

Sponsors & Collaborators

  • Keio University

    lead OTHER

Principal Investigators

  • Hisashi Sakamaki, M.D., Ph.D. · Tokyo Metropolitan Komagome Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2009-01-31
Completion
2011-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00270881 on ClinicalTrials.gov